乳头状结构、沙粒体和/或大量核内假包涵体是有用标准但不应作为甲状腺乳头状癌细胞学确诊的必需条件:207例手术随访的机构经验
本研究回顾207例原诊断为甲状腺乳头状癌(PTC)或可疑PTC(SPTC)的甲状腺细针穿刺(FNA)病例,应用限制性细胞学标准(RC)重新分类。RC在原PTC和SPTC病例中分别有83%和31%符合。应用RC后,部分临床显著癌(CSC)诊断升级或降级,但无NIFTP被误诊为恶性。结论:当其他核特征弥漫明显时,RC不应作为PTC确诊的必需条件,但有助于可疑病例的确诊。
要点
- RC在原PTC和SPTC病例中符合率分别为83%和31%。
- 应用RC后,29%原SPTC的CSC升级为PTC,17%原PTC的CSC降级为SPTC。
- 无NIFTP被诊断为恶性。
核心结论
- 当其他核特征弥漫明显时,RC不应作为PTC确诊的必需条件。
- 应用RC有助于病理医生在可疑病例中更明确地诊断PTC。
研究设计与样本
- 回顾性研究纳入207例原诊断为PTC或SPTC且有手术随访的甲状腺FNA病例。
- 将RC回顾性应用于病例作为诊断PTC的要求,不符合RC的病例重新分类为SPTC。
主要发现
- RC在原诊断为PTC的病例中符合118/142(83%),在原诊断为SPTC的病例中符合20/65(31%)。
- 应用RC后,原诊断为SPTC的CSC中29%(19/65)升级为PTC。
- 应用RC后,原诊断为PTC的CSC中17%(24/142)降级为SPTC。
- 无NIFTP被诊断为恶性。
关键数值与推荐
- RC包括乳头状结构、沙粒体或≥3个核内假包涵体。
临床怎么用
- 当其他核特征弥漫明显时,可不要求RC而直接确诊PTC。
- 对可疑病例应用RC有助于更明确地诊断PTC。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP) was introduced in 2016 replacing noninvasive follicular variant of papillary thyroid carcinoma, with recommendations to label them "noncancer." To avoid reducing risk of malignancy (ROM) and overdiagnosing NIFTP as malignant, some authors required restricted cytologic criteria (RC) for a definitive diagnosis of papillary thyroid carcinoma (PTC), including papillae, psammoma bodies. or ≥3 nuclear pseudoinclusions. Since then, NIFTP criteria have been revised, biologic behavior better understood, and incidence reported to be much lower than initially anticipated. This study examines the impact of RC on PTC cytologic diagnoses, ROM, and detection of clinically significant carcinomas (CSC). MATERIALS AND METHODS: A total of 207 thyroid FNAs originally diagnosed as PTC and suspicious for PTC (SPTC) with surgical follow-up were evaluated. RC were retrospectively applied to cases as a requirement for diagnosing PTC, and cases that did not meet RC were reclassified as SPTC. ROMs and diagnostic accuracies of pre- and post-RC diagnoses were correlated with followup CSC. RESULTS: RC were met in 118/142 (83%) and 20/65 (31%) of cases originally diagnosed as PTC and SPTC, respectively. Post-RC, 29% (19/65) of CSC originally diagnosed as SPTC were upgraded to PTC, and 17% (24/142) of CSC originally diagnosed as PTC were downgraded to SPTC. No NIFTPs were diagnosed as malignant. CONCLUSIONS: RC should not be required for a definitive diagnosis of PTC when other nuclear features of PTC are diffuse and overt. Applying RC, however, helps the pathologist arrive at a more definitive diagnosis of PTC in suspicious cases.
引用
- Elsheikh TM, Thomas M, Brainard J, et al. Papillae, psammoma bodies, and/or many nuclear pseudoinclusions are helpful criteria but should not be required for a definitive cytologic diagnosis of papillary thyroid carcinoma: An institutional experience of 207 cases with surgical follow up. Cancer Cytopathol. 2024. PMID: 38563725. doi:10.1002/cncy.22817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。